Aspire Biopharma Holdings, Inc.ASBPEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Aspire Biopharma Holdings, Inc. is a clinical-stage biopharmaceutical firm focused on developing novel therapeutic candidates for unmet needs in oncology and rare diseases, with primary operations across North America and key Asia-Pacific markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| SRIRAMA | 48.00% | 4.3M | — | 2023-09-05 |
| PowerUp Sponsor LLC | 31.90% | 2.9M | ▼ -48.00pp | 2023-08-28 |
| Harraden Circle Investments, LLC | 5.20% | 467.3K | — | 2024-05-28 |
| The Bank of Nova Scotia | 2.40% | 692.2K | — | 2024-07-30 |
| Glazer Capital, LLC | 0.34% | 30.6K | — | 2024-02-14 |
| Saba Capital Management, L.P. | 0.00% | 7.2K | — | 2024-02-08 |
| Adage Capital Partners, L.P. | 0.00% | 7.2K | — | 2024-02-07 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.